News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,879 Results
Type
Article (61402)
Company Profile (386)
Press Release (709091)
Section
Business (220263)
Career Advice (3338)
Deals (37764)
Drug Delivery (123)
Drug Development (86933)
Employer Resources (193)
FDA (17325)
Job Trends (16340)
News (373610)
Policy (36232)
Tag
Academia (2955)
Alliances (54345)
Alzheimer's disease (1425)
Approvals (17282)
Artificial intelligence (247)
Bankruptcy (387)
Best Places to Work (12378)
Biotechnology (271)
Breast cancer (246)
Cancer (1886)
Cardiovascular disease (150)
Career advice (2818)
CAR-T (147)
Cell therapy (409)
Clinical research (69627)
Collaboration (750)
Compensation (386)
COVID-19 (2820)
C-suite (186)
Data (1729)
Diabetes (236)
Diagnostics (6792)
Earnings (89102)
Employer resources (165)
Events (121634)
Executive appointments (620)
FDA (18308)
Funding (661)
Gene therapy (288)
GLP-1 (766)
Government (4950)
Healthcare (20458)
Infectious disease (2949)
Inflammatory bowel disease (136)
Interviews (643)
IPO (17179)
Job creations (4441)
Job search strategy (2316)
Layoffs (506)
Legal (8938)
Lung cancer (278)
Manufacturing (267)
Medical device (14260)
Medtech (14265)
Mergers & acquisitions (20972)
Metabolic disorders (637)
Neuroscience (1893)
NextGen: Class of 2025 (7369)
Non-profit (4976)
Northern California (2226)
Obesity (351)
Opinion (259)
Patents (187)
People (62632)
Phase I (21660)
Phase II (30497)
Phase III (22794)
Pipeline (809)
Postmarket research (3023)
Preclinical (9450)
Radiopharmaceuticals (264)
Rare diseases (363)
Real estate (6692)
Regulatory (24285)
Research institute (2611)
Resumes & cover letters (536)
Southern California (1918)
Startups (4035)
United States (20087)
Vaccines (715)
Weight loss (261)
Date
Today (79)
Last 7 days (834)
Last 30 days (2827)
Last 365 days (36299)
2025 (5669)
2024 (37273)
2023 (42181)
2022 (53440)
2021 (58136)
2020 (57030)
2019 (50501)
2018 (38332)
2017 (35454)
2016 (35636)
2015 (41768)
2014 (35759)
2013 (31297)
2012 (33430)
2011 (33932)
2010 (32581)
Location
Africa (1010)
Arizona (238)
Asia (44059)
Australia (7991)
California (5134)
Canada (1775)
China (434)
Colorado (235)
Connecticut (253)
Europe (98916)
Florida (748)
Georgia (182)
Illinois (519)
Indiana (285)
Maryland (806)
Massachusetts (3963)
Michigan (222)
Minnesota (370)
New Jersey (1461)
New York (1465)
North Carolina (953)
Northern California (2226)
Ohio (179)
Pennsylvania (1158)
South America (1396)
Southern California (1918)
Texas (755)
Utah (160)
Washington State (501)
770,879 Results for "verisante technology inc formerly known as t ray science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verisante Technology, Inc. Announces Update to Proposed RTO with SunRegen Healthcare AG
November 1, 2024
·
11 min read
Press Releases
Verisante Technology, Inc. Announces Proposed RTO with SunRegen Healthcare AG
August 14, 2024
·
14 min read
Press Releases
Averna Therapeutics, formerly known as Exsilio Therapeutics, Appoints Thomas M. Barnes, Ph.D., as Chief Executive Officer
January 27, 2025
·
3 min read
Verisante Technology, Inc. Announces 2023 AGM Results
Verisante Technology, Inc. is pleased to announce that at the 2023 Annual General Meeting held on December 18, 2023, in Vancouver, British Columbia, the Company’s shareholders voted in favour of all items of business.
December 20, 2023
·
1 min read
Verisante Technology Inc. Announces Shares for Debt Agreements
Verisante Technology, Inc. is pleased to announce it has agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.
September 7, 2023
·
2 min read
Verisante Technology, Inc. Announces Exchange Approval for Shares for Debt Transaction
Verisante Technology, Inc. previously announced on September 7, 2023, that it had agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.
October 5, 2023
·
3 min read
Breast cancer
AstraZeneca, Daiichi Sankyo’s ADC Wins First Approval Despite Mixed Data
Datroway, formerly known as Dato-DXd, significantly improved median progression-free survival in a Phase III study but failed to do so for overall survival.
January 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Press Releases
Precision X-Ray, Inc. Partners with Gilardoni SpA to Deliver X-Ray Blood Irradiation in the US
October 16, 2024
·
2 min read
Press Releases
Britannia Life Sciences Inc. Provides Corporate Update
January 29, 2025
·
3 min read
1 of 77,088
Next
